Skip to Content

Posts tagged with "Patents and IP"

  • Patents and IP

    The Supreme Court Makes Me Smile

    I wrote here about the Mayo v. Prometheus case, which dealt with patents on the use of thiopurines for autoimmune therapy. But the patents didn’t claim any thiopurine drugs themselves. Or their specific use for autoimmune therapy. Or vehicles to administer them in, or methods for their manufacture, or techniques to package them. Nothing as… Read More
  • Patents and IP

    Department of Lots of Nerve (Patent Applications Desk)

    When you file a patent application, there are plenty of things that the PTO wants you to include. One of the big ones is prior art: you’re supposed to disclose all the relevant inventions close to yours that you’re aware of, in order to show how your discovery is different. Prior art is naturally to… Read More
  • Patents and IP

    Independent Inventions

    Alex Tabarrok has an interesting post on the idea of patent protection for “independent invention”. This would be for cases when two people or organizations independently arrive at the same thing: In the minds of the public someone who infringes a patent is like a plagiarist or a thief–the infringer has copied someone else’s work… Read More
  • Academia (vs. Industry)

    Academia and Industry, Suing Each Other

    This is not the sort of academic-industry interaction I had in mind. There’s a gigantic lawsuit underway between Agios and the Abramson Institute at the University of Pennsylvania, alleging intellectual property theft. There are plenty more details at PatentBaristas: According to the complaint filed in the US District Court Southern District… Read More
  • Patents and IP

    Don’t Dose That Patient Until You Pay Up

    Now here is an awful, awful idea, and it’s made it all the way to the Supreme Court. Oral arguments were heard last week in Mayo Collaborative Services v. Prometheus Laboratories, and this one really has the potential to screw things up. Why am I so downbeat? Wait until you hear the basis of this… Read More
  • Patents and IP

    Amgen’s New Patent: Explanations, Anyone?

    Perhaps someone with a better knowledge of the biomolecule patent world can answer this one for me: just how did Amgen suddenly carve out a whole new patent lifetime for Enbrel? This is US patent 8,063,182, and it’s hard for me to unravel what the new parts are or how and why this got issued. Read More
  • Book Recommendations

    A New Book on Chemical Patents

    I wanted to mention a book I’ve received a review copy of recently: Writing Chemistry Patents and Intellectual Property: A Practical Guide. The description is accurate. It’ll be most useful for people who don’t have access to a lot of well-paid legal talent – or at least would like to get things into shape as… Read More
  • Patents and IP

    Patent Trolling, Money and Fun

    Now this is the sort of thing we don’t need. Nature News reports on a court case that I missed, Classen Immunotherapies, Inc. v. Biogen IDEC et al.. This is yet another run at the “can you patent natural phenomena?” argument, which seems to be an ever-upwelling spring for patent litigation: The court upheld a… Read More
  • Drug Industry History

    A Dish Best Served Cold

    And the well-known chem-blogger Milkshake knows how to serve it. See his latest post here. It doesn’t qiote make up for having one’s company bought out, having everyone moved and fired and hosed around, and having to go to court for the severance package that you were promised. . .but you have to take your… Read More
  • Patents and IP

    Chinese Research: Not Quite the Juggernaut?

    A perennial topic around here has been the state of scientific research in China (and other up-and-coming nations). There’s no doubt that the number of scientific publications from China has been increasing (be sure to read the comments to that post; there’s more to it than I made of it). But many of these papers… Read More
...567...